High expression of VIM was found in esophageal squamous cell carcinoma and non-small cell lung cancer tumors with much more advanced tumor status and a higher incidence of lymph node metastasis (Jin et al., 2010; Dauphin et al., 2013). Here, VIM is linked to non-small cell lung carcinoma.